Wearing a device that identifies other people’s facial expressions can help children with autism develop better social skills, a Stanford pilot study has demonstrated.
For release: August 2, 2018
From the Stanford University School of Medicine
Children with autism were able to improve their social skills by using a smartphone app paired with Google Glass to help them understand the emotions conveyed in people’s facial expressions, according to a pilot study by researchers at the Stanford University School of Medicine.
Prior to participating in the study, Alex, 9, found it overwhelming to look people in the eye. Gentle encouragement from his mother, Donji Cullenbine, hadn’t helped. “I would smile and say things like, ‘You looked at me three times today!’ But it didn’t really move the bar,” she said. Using Google Glass transformed how Alex felt about looking at faces, Cullenbine said. “It was a game environment in which he wanted to win — he wanted to guess right — and he got an instant reward when he did.”
The therapy, described in findings to be published online Aug. 2 in npj Digital Medicine, uses a Stanford-designed app that provides real-time cues about other people’s facial expressions to a child wearing Google Glass. The device, which was linked with a smartphone through a local wireless network, consists of a glasses-like frame equipped with a camera to record the wearer’s field of view, as well as a small screen and a speaker to give the wearer visual and audio information. As the child interacts with others, the app identifies and names their emotions through the Google Glass speaker or screen. After one to three months of regular use, parents reported that children with autism made more eye contact and related better to others.
The treatment could help fill a major gap in autism care: Right now, because of a shortage of trained therapists, children may wait as long as 18 months after an autism diagnosis to begin receiving treatment.
“We have too few autism practitioners,” said the study’s senior author, Dennis Wall, PhD, associate professor of pediatrics and of biomedical data science. Early autism therapy has been shown to be particularly effective, but many children aren’t treated quickly enough to get the maximum benefit, he said. “The only way to break through the problem is to create reliable, home-based treatment systems. It’s a really important unmet need.”
Autism is a developmental disorder that affects 1 in 59 children in the United States, with a higher prevalence in boys. It is characterized by social and communication deficits and repetitive behaviors.
The researchers named the new therapy “Superpower Glass” to help make it appealing to children. The therapy is based on applied behavior analysis, a well-studied autism treatment in which a clinician teaches emotion recognition using structured exercises such as flash cards depicting faces with different emotions. Although traditional applied behavior analysis helps children with autism, it has limitations: It must be delivered one-on-one by trained therapists, flash cards can’t always capture the full range of human emotion and children may struggle to transfer what they learn to their daily lives.
Wall’s team decided to try using applied behavior analysis principles in a way that would bring parents and everyday situations into the treatment process. They built a smartphone app that uses machine learning to recognize eight core facial expressions: happiness, sadness, anger, disgust, surprise, fear, neutral and contempt. The app was trained with hundreds of thousands of photos of faces showing the eight expressions, and also had a mechanism to allow people involved in the study to calibrate it to their own “neutral” faces if necessary.
Typically developing children learn to recognize emotions by engaging with people around them. For children with autism, it’s different. “They don’t pick those things up without focused treatment,” Wall said.
In the study, 14 families tested the Superpower Glass setup at home for an average of 10 weeks each. Each family had a child between the ages of 3 and 17 with a clinically confirmed autism diagnosis.
The families used the therapy for at least three 20-minute sessions per week. At the start and end of the study, parents completed questionnaires to provide detailed information about their child’s social skills. In interviews, parents and children also gave feedback about how the program worked for their families.
The researchers designed three ways to use the face-recognizing program: In “free play,” children wear Google Glass while interacting or playing with their families, and the software provides the wearer with a visual or auditory cue each time it recognizes an emotion on the face of someone in the field of view. There are also two game modes. In “guess my emotion,” a parent acts out a facial expression corresponding to one of the eight core emotions, and the child tries to identify it. The game helps families and researchers track children’s improvement at identifying emotions. In “capture the smile,” children give another person clues about the emotion they want to elicit, until the other person acts it out, which helps the researchers gauge the children’s understanding of different emotions.
Families told the researchers that the system was engaging, useful and fun. Kids were willing to wear the Google Glass, and the devices withstood the wear and tear of being used by children.
Twelve of the 14 families, including Alex’s, said their children made more eye contact after receiving the treatment. A few weeks into the trial, Alex began to realize that people’s faces hold clues to their feelings.
“He told me, ‘Mommy, I can read minds!’” Cullenbine said. “My heart sang. I’d like other parents to have the same experience.”
Families whose children had more severe autism were more likely to choose the game modes rather than free play, the researchers reported.
The children’s mean score on the SRS-2, a questionnaire completed by parents to evaluate children’s social skills, decreased by 7.38 points during the study, indicating less severe symptoms of autism. None of the participants’ SRS-2 scores increased during the study, meaning nobody’s autism symptoms worsened. Six of the 14 participants had large enough declines in their scores to move down one step in the severity of their autism classification: four from “severe” to “moderate,” one from “moderate” to “mild” and one from “mild” to “normal.”
The results should be interpreted with caution since the study did not have a control arm, Wall said. However, the findings are promising, he added.
Parents’ comments in interviews helped illustrate the improvements, he said. “Parents said things like ‘A switch has been flipped; my child is looking at me.’ Or ‘Suddenly the teacher is telling me that my child is engaging in the classroom.’ It was really heartwarming and super-encouraging for us to hear,” Wall said.
His team is currently completing a larger, randomized trial of the therapy. In addition, they also plan to test the therapy in children who have just been diagnosed with autism and are on a waiting list for treatment. Stanford University has filed a patent application for the technology.
Information about the project is available online.
The study’s other Stanford authors are clinical research coordinators Jena Daniels and Jessey Schwartz; graduate students Catalin Voss and Peter Washington; postdoctoral scholar Nick Haber, PhD; software engineer Azar Fazel; software developer Aaron Kline; Carl Feinstein, MD, professor emeritus of psychiatry and behavioral sciences; and Terry Winograd, PhD, professor emeritus of computer science.
Wall, Feinstein and Winograd are members of Stanford Bio-X and the Stanford Child Health Research Institute. Wall is also a member of the Stanford Neurosciences Institute.
The research was funded by grants from the National Institutes of Health (grants 1R21HD091500 and 1R01EB025025), Stanford’s Clinical and Translational Science Award (NIH grant UL1TR001085), the David and Lucile Packard Foundation, the Beckman Center for Molecular and Genetic Medicine, the Wallace H. Coulter Foundation, Stanford’s Walter V. and Idun Berry Postdoctoral Fellowship Program, the Stanford Child Health Research Institute, the Dekeyser and Friends Foundation and the Mosbacher Family Fund for Autism Research, as well as an individual gift from Peter Sullivan. The researchers received an in-kind gift from Google of 35 Google Glass devices as well as technical assistance from the company, and an in-kind grant of Amazon Web Services Founder Support.
Stanford’s Department of Pediatrics also supported the work.
Media Contact:
Erin Digitale
digitale@stanford.edu
(650) 724-9175
Margarita Gallardo
mjgallardo@stanford.edu
(650) 723-7897
Stanford Medicine Children’s Health, with Lucile Packard Children’s Hospital Stanford at its center, is the Bay Area’s largest health care system exclusively dedicated to children and expectant mothers. Our network of care includes more than 65 locations across Northern California and more than 85 locations in the U.S. Western region. Along with Stanford Health Care and the Stanford School of Medicine, we are part of Stanford Medicine, an ecosystem harnessing the potential of biomedicine through collaborative research, education, and clinical care to improve health outcomes around the world. We are a nonprofit organization committed to supporting the community through meaningful outreach programs and services and providing necessary medical care to families, regardless of their ability to pay. Discover more at stanfordchildrens.org.
Connect with us:
Download our App: